Latest Teva Pharmaceuticals News & Updates

See the latest news and media coverage for Teva. We track all announcements, press releases, and industry mentions in real time, all in one place.

Teva Pharmaceuticals (Teva)

Innovative biopharmaceutical company with a generics business

tevapharm.com

Headquarters: Tel-Aviv, Israel
Company type: Public company
Number of employees: 30,000+
Industry: Pharmaceuticals

Last updated Today

Latest news about Teva Pharmaceuticals (Teva)

In short: Teva reached investment grade and raised its 2026 outlook following record innovative drug sales and the acquisition of Emalex Biosciences.

Company announcements

August 19 Teva

Teva receives FDA acceptance of the ecopipam new drug application

The first-in-class dopamine antagonist addresses unmet pediatric needs supported by positive Phase 2b and 3 data, with approval targeted for early 2027.

August 11 Teva

Teva's credit rating upgraded to investment grade by Moody's

Moody's raised Teva's corporate rating to Baa3 from Ba1 with a stable outlook, citing successful growth strategy, innovation, and debt reduction.

July 30 Teva

Teva summarizes its Q2 2026 transformation progress

Released July 30, 2026, the AI-generated recap covers innovative portfolio momentum, pipeline progress, and strategic execution.

July 29 Teva

Teva reports Q2 results and raises outlook

Revenue was $4.1 billion, innovative brands grew 43% year-over-year, and the company raised its 2026 outlook for all three.

Media coverage

August 28 Pharmaceutical Executive

Pharmaceutical Executive Daily: DualityBio and Teva Strike Major Biopharma Deals

FDA approves three new therapies spanning autoimmune disease, HIV, and cardiovascular risk, DualityBio and Teva strike major biopharma deals, and Israel Ortiz makes the case...

August 27 The Globe and Mail

Teva Announces Proposed Acquisition of a Novel Neuroscience Product Reinforcing Disciplined Business Development Approach Under Pivot to Growth Strategy

BXCL501, a novel dexmedetomidine sublingual film, is under FDA review for potential at-home (outpatient) use for the acute treatment of agitation associated with schizophrenia or...

August 24 The Jerusalem Post

Turkey probes Israeli pharmaceutical company Teva over claims it blocked rivals in drug market

The Turkish investigation was opened against Teva International, its subsidiary Teva Europe, and its subsidiary in Turkey to ...

August 23 Globes

Teva share price hits 10-year high

The share price of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) hit a 10-year high last week. The Israeli pharmaceutical company's share price closed...

Never miss news about Teva

Track Teva and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Teva competitors & trending companies

Browse news for competitors to Teva and other trending companies.